Perez-Johnston, Rocio http://orcid.org/0000-0001-9063-2615
Araujo-Filho, Jose
Mckenney, Anna S.
Gangai, Natalie
Plodkowski, Andrew J.
Liu, Corinne C.
Sawan, Peter
Taur, Ying
Morjaria, Sejal M.
Ginsberg, Michelle S.
Funding for this research was provided by:
National Cancer Institute (P30 CA008748.)
Article History
Received: 30 March 2021
Revised: 10 August 2021
Accepted: 24 August 2021
First Online: 30 October 2021
Declarations
:
: The scientific guarantor of this publication is Rocio Perez-Johnston, MD.
: The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.
: One of the authors (Natalie Gangai, MPH) has significant statistical expertise.
: Written informed consent was waived by the Institutional Review Board.
: Institutional Review Board approval was obtained.
: Some patients in our study sample were described in the supplemental material: “Robilotti EV, Babady NE, Mead PA, Rolling T, Perez-Johnston R, Bernardes M, Bogler Y, Caldararo M, Figueroa CJ, Glickman MS, Joanow A, Kaltsas A, Lee YJ, Lucca A, Mariano A, Morjaria S, Nawar T, Papanicolaou GA, Predmore J, Redelman-Sidi G, Schmidt E, Seo SK, Sepkowitz K, Shah MK, Wolchok JD, Hohl TM, Taur Y, Kamboj M. Determinants of COVID-19 disease severity in patients with cancer<i>. Nat Med</i>. 2020 Aug;26(8):1218-1223. ExternalRef removed. Epub 2020 Jun 24. PMID: 32581323.”The time period of inclusion of patients was different (March 10th to April 7th). The radiologic data was not used in their analysis of outcome but only described in the supplemental material including both chest radiograph and computed tomography without establishing a cutoff period between the diagnosis and the time of the imaging studies. While the previous study clinically followed patients for a 30-day period, they did not include and radiologic follow-up.
: • retrospective• observational• performed at one institution
Free to read: This content has been made available to all.